The panel recommended allowing compounding pharmacies to produce popular but unproven BPC-157 and KPV peptides.

In a victory for Robert F. Kennedy Jr.’s “MAHA” agenda, panelists narrowly recommended broader use of four peptides despite a lack of substantive evidence supporting their…

Federal health advisers are meeting to review a group of controversial chemicals called peptides